- Category
- Small (2023-24)
- Udyam number
- UDYAM-CH-01-0003923

About Eswar Therapeutics Private Limited
Data last updated:
Eswar Therapeutics Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304CH2017PTC041467. Its GSTIN is 04AAECE5982G1ZL (Chandigarh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vikram Khungar (Managing Director) and Kashmiri Lal Khunger.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 4 – A Raipur Kalan, Chandigarh, India – 160102.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.06 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.29 Cr (net margin 2.4%) and EBITDA of ₹2.74 Cr (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 25% over five years.
The company has about 140 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Eswar Therapeutics. As per MCA filings, the company has open charges of ₹5.19 Cr and satisfied charges of ₹1.69 Cr on record. Court records list 10 cases involving the company, including 2 filed by the company and 8 filed against it; 1 case is pending.
Eswar Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0003923). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eswartherapeutics.com.
Company details
Recognitions & Rankings of Eswar Therapeutics
Contact details
Eswar Therapeutics Private Limited's registered office is in Chandigarh, Chandigarh. Its website is eswartherapeutics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 4 – A Raipur Kalan, Chandigarh, India – 160102
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Eswar Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eswar Therapeutics operates one associated brand: Eswar Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provision of pharmaceutical and nutritional products in India. | eswartherapeutics.com |
Business activity
The main business activity of Eswar Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eswar Therapeutics Private Limited, buy the company report.
Financials of Eswar Therapeutics Private Limited
FY 2025 filings availableEswar Therapeutics Private Limited reported revenue of ₹54.06 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 24% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.29 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eswar Therapeutics Private Limited, buy the company report.
Board of directors of Eswar Therapeutics Private Limited
Eswar Therapeutics has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kashmiri Lal Khunger | Director | 28 Nov 2023 | 2 Years 11 Months | Current |
| Vikram Khungar Also directs: Eswar Healthcare LLP, Elinza Pharmaceuticals Private Limited | Managing Director | 25 Jan 2019 | 7 Years 9 Months | Current |
| Raj Khurana Also directs: Elinza Pharmaceuticals Private Limited | Director | 01 Apr 2023 | 3 Years 7 Months | Current |
Peer comparison
Eswar Therapeutics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dezzey Sweeteners Private Limited | ₹54.1 Cr (FY 2025) | -24.0% | Indore, Madhya Pradesh, India | |||
| HMM Aluminium Private Limited | ₹54.09 Cr (FY 2025) | 11.0% | Chandauli, Uttar Pradesh, India | |||
| Samit Sales Pvt Ltd | ₹54.09 Cr (FY 2024) | 3.0% | Faridabad, Haryana, India | |||
| Laxmi Solar Power Systems Private Limited | ₹54.08 Cr (FY 2025) | 409.0% | Raipur, Chhattisgarh, India | |||
| Nikunj Exports Private Limited | ₹54.06 Cr (FY 2025) | -18.0% | Rajasthan, India | |||
| Eswar Therapeutics Private Limitedthis company | ₹54.06 Cr (FY 2025) | ₹1.29 Cr | 2.4% | 24.0% | 140 | Chandigarh, India |
| Petra Industries Private Limited | ₹54.05 Cr (FY 2025) | 24.0% | Bhavnagar, Gujarat, India | |||
| VPB Infratech Private Limited | ₹54.03 Cr (FY 2025) | 138.0% | Jaipur, Rajasthan, India | |||
| Su-Dev Group Private Limited | ₹54.03 Cr (FY 2025) | 24.0% | Ahmedabad, Gujarat, India | |||
| Ease Dealcom Private Limited | ₹54.03 Cr (FY 2025) | 209.0% | Kolkata, West Bengal, India | |||
| Jinendra Enterprise Private Limited | ₹54.02 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Eswar Therapeutics Private Limited, buy the company report.
Auditor
Eswar Therapeutics Private Limited is audited by NITIN MAHAJAN & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NITIN MAHAJAN & ASSOCIATES | FY 2024 | 019837N |
Shareholding
The shareholding of Eswar Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eswar Therapeutics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2025 | 101174374 | Indian Overseas Bank | ₹12 Lakh | Open | |
| 28 Jul 2025 | 101135228 | Hdfc Bank Limited | ₹5.76 Lakh | Open | |
| 29 May 2025 | 101104160 | Hdfc Bank Limited | ₹7.24 Lakh | Open | |
| 21 Feb 2025 | 101052220 | Hdfc Bank Limited | ₹8.36 Lakh | Open | |
| 16 Dec 2024 | 101030587 | Hdfc Bank Limited | ₹7 Lakh | Open |
To see the full charge records of Eswar Therapeutics Private Limited, buy the company report.
Total charge records: 20 View all charges
Legal cases
Eswar Therapeutics Private Limited has 10 court cases on record: 2 filed by Eswar Therapeutics, 8 filed against it. 1 case is pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 1 |
| High courts | 3 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Srinagar, Jammu and Kashmir | Court case (Original Suits (OS)) | Filed against the company by an individual | Pending |
| District court, Bilaspur, Himachal Pradesh | Court case (Motor Vehc Act) | Filed against the company by State of HP | Disposed |
| High Court of Jammu and Kashmir and Ladakh | Appeal | Filed against the company by M/S Ibm Associates, Pharmaceutical Distributers Th Managing Partner | Disposed |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against Union of India Through Its Secretary | Disposed |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against Union of India Through Its Secretary Ministry of Finance | Disposed |
To see the full case history of Eswar Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eswar Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eswar Therapeutics Private Limited has a workforce of 140 employees on its EPFO records as of Jan 22, 2025, across 1 active EPFO establishment.
GST
Eswar Therapeutics has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECE5982G1ZL | Chandigarh | Active | 01 Jul 2017 |
| 02AAECE5982G1ZP | Himachal Pradesh | Active | 03 Dec 2024 |
To see the full GST registrations and return filing status of Eswar Therapeutics Private Limited, buy the company report.
Recent activity
Eswar Therapeutics Private Limited has 8 board changes on record since 2019: 3 appointments and 5 cessations. The latest: Vikram Khungar ceased to be Director on 31 Mar 2025.
23 earlier events are in the company report.
Frequently asked questions
Eswar Therapeutics is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 April 2017 (9+ years old) and is registered under CIN U24304CH2017PTC041467.
Eswar Therapeutics has 3 current directors:
- Vikram Khungar - Managing Director
- Kashmiri Lal Khunger - Director
- Raj Khurana - Director
The latest financial statements of Eswar Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Eswar Therapeutics is 04AAECE5982G1ZL, registered in Chandigarh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAECE5982G1ZP (Himachal Pradesh).
The CIN (Corporate Identification Number) of Eswar Therapeutics is U24304CH2017PTC041467. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eswar Therapeutics has 10 court cases on record: 2 filed by the company and 8 filed against it. 1 is pending. Most are in the district courts.
Eswar Therapeutics was incorporated on 05 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Eswar Therapeutics by revenue are Dezzey Sweeteners Private Limited, HMM Aluminium Private Limited, Samit Sales Pvt Ltd, Laxmi Solar Power Systems Private Limited, Nikunj Exports Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Vikram Khungar ceased to be Director on 31 Mar 2025. Kashmiri Lal Khunger ceased to be Additional Director on 29 Sep 2024. Kashmiri Lal Khunger was appointed as Director on 28 Nov 2023. Eswar Therapeutics has 8 board changes on record in total.
Yes, Eswar Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0003923).
Eswar Therapeutics can be reached through the website eswartherapeutics.com. Its registered office is in Chandigarh, India.

